Jonathan Canaani Selected Research

Jonathan Canaani Research Topics

20	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2022 - 03/2016
18	Leukemia 01/2022 - 01/2017
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2022 - 10/2017
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 10/2017
3	Inflammation (Inflammations) 06/2013 - 08/2008
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2020 - 10/2016
2	Neoplasms (Cancer) 06/2018 - 05/2008
2	Carcinogenesis 06/2018 - 05/2008
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2013 - 08/2008
1	Cardiotoxicity 02/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Left Ventricular Dysfunction 11/2019
1	Multiple Myeloma 10/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2019
1	Residual Neoplasm 11/2018
1	Philadelphia Chromosome 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 03/2016
1	Immune Reconstitution Inflammatory Syndrome 04/2013
1	Lymphoma (Lymphomas) 04/2013
1	Lymphadenopathy 02/2012
1	Anemia 02/2012
1	Liver Diseases (Liver Disease) 08/2008
1	Carcinoma (Carcinomatosis) 05/2008
1	Endometrial Hyperplasia 05/2008
1	Hyperplasia 05/2008
1	Endometrial Neoplasms (Endometrial Cancer) 05/2008

5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2017
3	gilteritinibIBA 09/2022 - 01/2019
2	AnthracyclinesIBA 02/2021 - 11/2019
2	heparanaseIBA 06/2018 - 05/2008
1	Pyridinolcarbamate (P23)IBA 01/2022
1	fms-Like Tyrosine Kinase 3IBA 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	anthraceneIBA 02/2021
1	bisantreneIBA 02/2021
1	venetoclaxIBA 01/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2020
1	PanobinostatIBA 10/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	fludarabineIBA 01/2019
1	treosulfanIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 06/2018
1	DNA (Deoxyribonucleic Acid)IBA 06/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 10/2017
1	GlobulinsIBA 10/2017
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 10/2017
1	Cholinergic Agents (Cholinergics)IBA 06/2013
1	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2013
1	Rituximab (Mabthera)FDA Link 04/2013
1	CytokinesIBA 06/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2012
1	C-Reactive ProteinIBA 08/2008
1	Biomarkers (Surrogate Marker)IBA 08/2008

14	Transplantation 01/2022 - 01/2017
11	Stem Cell Transplantation 01/2021 - 04/2017
6	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2017
5	Therapeutics 02/2021 - 03/2016
4	Drug Therapy (Chemotherapy) 03/2022 - 01/2021
4	Induction Chemotherapy 02/2022 - 11/2019
4	Cell Transplantation 01/2022 - 08/2017
2	Haploidentical Transplantation 11/2018 - 01/2017
1	Traction 01/2021
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2021
1	Splenectomy 01/2021